CD8A and neoplasm: Studies have shown that tumor cell-derived EVs can target neighboring macrophages and modulate their conversion to M2 (Li X. et al., 2018); in turn, M2 macrophage-derived EVs can facilitate tumor progression and CD8+ T cell exhaustion in HCC mice (Chen J. et al., 2021; Pu et al., 2021).